The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.
Cannabis securities continued to be active in November as the sector weathered a significant price correction.
According to data from OTC Markets Group, several cannabis securities experienced volume increases in November, despite lower trading volumes overall due to the Thanksgiving holiday.
Only 15 of the 30 most actively traded securities on the OTCQX Market, the top tier of OTC Markets, experienced month-over-month volume increases in November. But of those 15, five were cannabis companies. Those companies, Trulieve Cannabis Corporation TCNNF, Charlotte’s Web Holdings Inc. CWBHF, Acreage Holdings Inc. ACRGF, Green Thumb Industries Inc. GTBIF, and Medipharm Labs Corporation MEDIF, experienced an average volume increase of 37% in November compared to October. Trulieve led the way for the group, with a 48% month-over-month increase in volume.
Elsewhere on the market, French bank BNP Paribas BNPQY and German apparel-maker adidas AG ADDYY were the two companies whose securities had the greatest volume increases in November—their shares changed hands 182% and 105% more than in October respectively.
On the OTCQB Market, preferred shares of Chesapeake Energy Corp. CHKDP experienced by far the biggest month-over-month volume increase, with shares traded 2,644% more in November than in October. The oil and gas company, which has struggled to get its financials in order, announced a series of debt financing moves in early December that would appear to give it some much-needed financial flexibility.
Roughly $20 million worth of CHKDP traded last month—approximately half of the security’s total year-to-date dollar volume. Another preferred share class, CHKDG, saw its volume increase 217% last month as well.
Other OTCQB securities with dramatic volume increases in November include Q BioMed Inc. QBIO (volume increased 840%), Alpine 4 Technologies Ltd. ALPP (337%), John Marshall Bancorp, Inc. JMSB (237%), and Nextech AR Solutions Corp. NEXCF (211%).
Overall, these were the 10 most actively traded securities on the OTCQX and OTCQB Markets in November.
OTCQX
Company Name | Country | November Volume ($) |
---|---|---|
Roche Holding Ltd RHHBY | Switzerland | $911,125,979 |
Grayscale Bitcoin Trust (BTC) GBTC | U.S. | $488,683,023 |
BNP Paribas BNPQY | France | $306,151,251 |
adidas AG ADDYY | German | $234,179,040 |
Imperial Brands PLC (OTCQX: IMBBY) | United Kingdom | $220,879,564 |
Danone DANOY | France | $214,019,801 |
Charlottes Web Hldgs Inc. CWBHF | U.S. | $159,786,388 |
Infineon Technologies AG IFNNY | Germany | $92,963,577 |
Zurich Insurance Group Ltd (OTCQX: ZURVY) | Switzerland | $88,763,429 |
BASF SE (OTCQX: BASFY) | Germany | $60,637,536 |
OTCQB
Company | Country | November Volume ($) |
---|---|---|
Fannie Mae FNMAS | U.S. | $358,757,068 |
Freddie Mac FMCKJ | U.S. | $308,676,266 |
Fannie Mae FNMA | U.S. | $258,186,331 |
Freddie Mac FMCC | U.S. | $71,020,858 |
CV Sciences, Inc. CVSI | U.S. | $34,469,729 |
Alpine 4 Technologies Ltd. ALPP | U.S. | $31,356,332 |
Fannie Mae FNMAT | U.S. | $26,090,531 |
Chesapeake Energy Corp. CHKDP | U.S. | $20,211,686 |
Q BioMed Inc. QBIO | U.S. | $13,541,993 |
Fannie Mae FNMFN | U.S. | $13,386,491 |
The preceding post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Although the piece is not and should not be construed as editorial content, the sponsored content team works to ensure that any and all information contained within is true and accurate to the best of their knowledge and research. This content is for informational purposes only and not intended to be investing advice.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.